---
title: Fireside Chat at Precision in Clinical Trials Boston
description: Discover early risk detection in clinical trials by measuring site readiness during initiation. Join us at the Precision in Clinical Trials Summit to learn more.
image: https://www.info.archemedx.com/hubfs/PCT%202026%20LI%20Image.jpeg
---

[![](https://www.info.archemedx.com/hs-fs/hubfs/ArcheMedX_2019-1.png?width=556&height=156&name=ArcheMedX_2019-1.png)](https://www.archemedx.com)

# You’re Seeing Trial Risk Too Late

Most signals show up once the study is underway. By then, teams are reacting to issues that have been building for weeks.

What if you could identify risk during site initiation instead?

Join our fireside chat at the **Precision in Clinical Trials Summit** or schedule a 1:1 meeting to explore how measuring readiness during site initiation reveals risk earlier.

[Schedule Time in Boston](https://www.info.archemedx.com/meetings/joelselzer/pct-26-boston?hsLang=en)

[Save Your Spot at PCT](https://events.precision-globe.com/register/27)

![PCT 2026 LI Image](https://www.info.archemedx.com/hs-fs/hubfs/PCT%202026%20LI%20Image.jpeg?width=800&height=523&name=PCT%202026%20LI%20Image.jpeg "PCT 2026 LI Image")

# We’ve Improved Risk Detection. Not Timing

##### Most trial teams have invested heavily in RBQM. But the signals it generates usually show up once the study is underway.

##### By then, teams are reacting to issues that have been building for weeks.

![Trial risk timeline](https://www.info.archemedx.com/hs-fs/hubfs/Trial%20risk%20timeline.png?width=1000&height=667&name=Trial%20risk%20timeline.png "Trial risk timeline")

##### Risk doesn’t start downstream in the data. It starts with **human variability.**

Differences in how sites interpret and execute the protocol matter more than most teams realize. That variability is measurable, and it shows up before the study starts.

Measuring readiness during site activation creates an early warning signal that allows teams to act sooner.

*As outlined in a recent [Applied Clinical Trials](https://www.appliedclinicaltrialsonline.com/view/earliest-warning-sign-measuring-readiness-training-predicts-trial-risk-data) article, measuring readiness during training can reveal risk before it shows up in trial data.*

---

![PCT Summit Fireside Chat_Boston 2026](https://www.info.archemedx.com/hs-fs/hubfs/PCT%20Summit%20Fireside%20Chat_Boston%202026.png?width=1536&height=1024&name=PCT%20Summit%20Fireside%20Chat_Boston%202026.png)

## Join the Conversation at PCT Boston

We’re still identifying trial risk after it’s already impacting execution.

This session focuses on a different approach. Measuring readiness during site initiation to surface risk earlier, before first patient in and before performance starts to drift.

 

[Save Your Spot →](https://events.precision-globe.com/register/27)

We’ll be continuing these conversations throughout PCT.

## Let’s Meet in Boston

We’ll be meeting with clinical and operational leaders throughout PCT.

If you’re rethinking how your team identifies and manages execution risk, we’d welcome the conversation.

### Request a Meeting

[![](https://www.info.archemedx.com/hs-fs/hubfs/ArcheMedX_2019-1.png?width=556&height=156&name=ArcheMedX_2019-1.png)](http://archemedx.com)

© 2026 ArcheMedX. All rights reserved.